Integrative Clinical Genomics of Advanced Prostate Cancer

Dan R. Robinson, Eliezer M. Van Allen, Yi-Mi Wu, +70

Cell

UrologyGenitourinary CancerMedicineIntegrative Clinical GenomicsCancer Genomics +4

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

Joaquı́n Mateo, Suzanne Carreira, Shahneen Sandhu, +48

New England Journal of Medicine

Plasma <i>AR</i> and abiraterone-resistant prostate cancer

Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, +20

Science Translational Medicine

Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition

Jane Goodall, Joaquı́n Mateo, Wei Yuan, +31

Cancer Discovery

Genomics of lethal prostate cancer at diagnosis and castration resistance

Joaquı́n Mateo, George Seed, Cláudia Bertan, +32

Journal of Clinical Investigation

UrologyOncologyGenomic AberrationsTumor HeterogeneityDdr Gene Defects +11

PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate

Roberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, +21

European Urology

Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer

Daniel Nava Rodrigues, Pasquale Rescigno, David Liu, +49

Journal of Clinical Investigation

Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use

David Lorente, Joaquı́n Mateo, Arnoud J. Templeton, +8

Annals of Oncology

UrologyBaseline Neutrophil–lymphocyte RatioMedicineCancer ManagementCancer Treatment +5

SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity

Gunther Boysen, Daniel Nava Rodrigues, Pasquale Rescigno, +30

Clinical Cancer Research

Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer

Jonathan Welti, Daniel Nava Rodrigues, Adam Sharp, +8

European Urology